Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

NCT03869866 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers (Meningococcal Infection)

Interventions

BIOLOGICAL: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine MenACYW conjugate vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company